TY - JOUR
T1 - Biological functions of catalytic antibodies
AU - Latry, V.
AU - Bayry, J.
AU - Thorenoor, N.
AU - Kazatchkine, M. D.
AU - Kaveri, S. V.
AU - Lacroix-Desmazes, S.
PY - 2003
Y1 - 2003
N2 - The extent of the repertoire of antibodies that may be potentially produced by the organism is determined by the number of VH, D H, JH, VL and JL genes that encode the variable regions of immunoglobulins and by the junctional diversity that occurs at the time of somatic rearrangement. This potential repertoire includes antibodies the antigen binding site of which may recognize external as well as autologous antigens (the later being referred to as natural antibodies), or may structurally resemble the active site of enzymes and be endowed with enzymatic activity. Under physiological conditions, B-cell clones that produce antibodies naturally endowed with catalytic activity are negatively regulated and subjected to apoptosis. Catalytic antibodies are expressed only following active immunization of the organism using haptens that are analogs of transitions states for chemical reactions, or if the physiological regulatory mechanisms that control the expression of catalytic antibody-producing B-cell clones are perturbed, e.g. in the context of pregnancy or in the course of autoimmune diseases.
AB - The extent of the repertoire of antibodies that may be potentially produced by the organism is determined by the number of VH, D H, JH, VL and JL genes that encode the variable regions of immunoglobulins and by the junctional diversity that occurs at the time of somatic rearrangement. This potential repertoire includes antibodies the antigen binding site of which may recognize external as well as autologous antigens (the later being referred to as natural antibodies), or may structurally resemble the active site of enzymes and be endowed with enzymatic activity. Under physiological conditions, B-cell clones that produce antibodies naturally endowed with catalytic activity are negatively regulated and subjected to apoptosis. Catalytic antibodies are expressed only following active immunization of the organism using haptens that are analogs of transitions states for chemical reactions, or if the physiological regulatory mechanisms that control the expression of catalytic antibody-producing B-cell clones are perturbed, e.g. in the context of pregnancy or in the course of autoimmune diseases.
UR - http://www.scopus.com/inward/record.url?scp=0346058334&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0346058334&partnerID=8YFLogxK
U2 - 10.1159/000075860
DO - 10.1159/000075860
M3 - Review article
AN - SCOPUS:0346058334
SN - 1660-3796
VL - 30
SP - 264
EP - 267
JO - Transfusion Medicine and Hemotherapy
JF - Transfusion Medicine and Hemotherapy
IS - 6
ER -